Lista de obras - Claus Johansen - Dominio Público Uruguay

1alpha,25(OH)(2)D(3) regulates NF-kappaB DNA binding activity in cultured normal human keratinocytes through an increase in IkappaBalpha expression.

artículo científico publicado en 2004

1alpha,25-dihydroxyvitamin D3 induced differentiation of cultured human keratinocytes is accompanied by a PKC-independent regulation of AP-1 DNA binding activity

artículo científico publicado en 2000

1alpha,25-dihydroxyvitamin D3 stimulates activator protein 1 DNA-binding activity by a phosphatidylinositol 3-kinase/Ras/MEK/extracellular signal regulated kinase 1/2 and c-Jun N-terminal kinase 1-dependent increase in c-Fos, Fra1, and c-Jun express

artículo científico publicado en 2003

A Characterization of the expression of 14-3-3 isoforms in psoriasis, basal cell carcinoma, atopic dermatitis and contact dermatitis

artículo científico publicado en 2010

Activator protein 1 DNA binding activity is decreased in lesional psoriatic skin compared with nonlesional psoriatic skin.

artículo científico publicado en 2004

Adalimumab therapy rapidly inhibits p38 mitogen-activated protein kinase activity in lesional psoriatic skin preceding clinical improvement.

artículo científico publicado en 2010

Aldara®-induced skin inflammation: studies of patients with psoriasis.

artículo científico publicado en 2014

Anti-inflammatory effect of a retrovirus-derived immunosuppressive peptide in mouse models

artículo científico publicado en 2013

Antibiotics inhibit tumor and disease activity in cutaneous T-cell lymphoma

scientific article published on 22 July 2019

CCL27 expression is regulated by both p38 MAPK and IKKβ signalling pathways.

artículo científico publicado en 2011

Caspase-5 expression is upregulated in lesional psoriatic skin

artículo científico publicado en 2010

Changes in mRNA expression precede changes in microRNA expression in lesional psoriatic skin during treatment with adalimumab

artículo científico publicado en 2015

Characterization of TNF-α- and IL-17A-Mediated Synergistic Induction of DEFB4 Gene Expression in Human Keratinocytes through IκBζ.

artículo científico publicado en 2016

Characterization of the interleukin-17 isoforms and receptors in lesional psoriatic skin

artículo científico publicado en 2009

Comment on 'Tumour necrosis factor-α plays a significant role in the Aldara-induced skin inflammation in mice': reply from authors.

artículo científico publicado en 2016

Comparative Analysis of Two Gene-Targeting Approaches Challenges the Tumor-Suppressive Role of the Protein Kinase MK5/PRAK

artículo científico publicado en 2015

Differential Effects of Digoxin on Imiquimod-Induced Psoriasis-Like Skin Inflammation on the Ear and Back

artículo científico publicado en 2018

Dimethylfumarate inhibits MIF-induced proliferation of keratinocytes by inhibiting MSK1 and RSK1 activation and by inducing nuclear p-c-Jun (S63) and p-p53 (S15) expression.

artículo científico publicado en 2011

Dimethylfumarate specifically inhibits the mitogen and stress-activated kinases 1 and 2 (MSK1/2): possible role for its anti-psoriatic effect.

artículo científico publicado en 2007

Efficacy of ustekinumab in palmoplantar pustulosis and palmoplantar pustular psoriasis

artículo científico publicado en 2014

Expression and Localization of Peroxisome Proliferator-Activated Receptors and Nuclear Factor κB in Normal and Lesional Psoriatic Skin

Generation and Culturing of Primary Human Keratinocytes from Adult Skin.

artículo científico publicado en 2017

IL-17F regulates psoriasis-associated genes through IκBζ.

artículo científico publicado en 2016

IL-20 gene expression is induced by IL-1beta through mitogen-activated protein kinase and NF-kappaB-dependent mechanisms

artículo científico publicado en 2007

IL-20, IL-21 and p40: potential biomarkers of treatment response for ustekinumab.

artículo científico publicado en 2013

IL-8 and p53 are inversely regulated through JNK, p38 and NF-kappaB p65 in HepG2 cells during an inflammatory response.

artículo científico publicado en 2008

Inflammasomes and inflammatory caspases in skin inflammation

artículo científico publicado en 2008

Inflammation-induced alterations in the skin barrier function: implications in atopic dermatitis.

artículo científico publicado en 2012

Inflammatory cytokines break down intrinsic immunological tolerance of human primary keratinocytes to cytosolic DNA.

artículo científico publicado en 2014

Interleukin 20 protein locates to distinct mononuclear cells in psoriatic skin

artículo científico publicado en 2014

Interleukin 20 regulates dendritic cell migration and expression of co-stimulatory molecules.

artículo científico publicado en 2016

Interleukin-23 in early disease development in rheumatoid arthritis.

artículo científico publicado en 2015

Inverse regulation of the nuclear factor-kappaB binding to the p53 and interleukin-8 kappaB response elements in lesional psoriatic skin.

artículo científico publicado en 2005

Investigating the Role of I Kappa B Kinase ε in the Pathogenesis of Psoriasis

scientific article published on 01 October 2019

IκBζ is a key driver in the development of psoriasis

artículo científico publicado en 2015

IκBζ: A key protein in the pathogenesis of psoriasis

artículo científico publicado en 2015

Kinetics and differential expression of the skin-related chemokines CCL27 and CCL17 in psoriasis, atopic dermatitis and allergic contact dermatitis

artículo científico publicado en 2011

Langerhans cell markers CD1a and CD207 are the most rapidly responding genes in lesional psoriatic skin following adalimumab treatment.

artículo científico publicado en 2017

Leptin deficiency in mice counteracts imiquimod (IMQ)-induced psoriasis-like skin inflammation while leptin stimulation induces inflammation in human keratinocytes.

artículo científico publicado en 2016

Lysophosphatidylcholine induces keratinocyte differentiation and upregulation of AP-1- and NF-kappaB DNA-binding activity

artículo científico publicado en 2004

MK2 regulates the early stages of skin tumor promotion.

artículo científico publicado en 2009

Measuring serum concentrations of interleukin-33 in atopic dermatitis is associated with potential false positive results.

artículo científico publicado en 2016

Mice lacking MSK1 and MSK2 show reduced skin tumor development in a two-stage chemical carcinogenesis model.

artículo científico publicado en 2011

MicroRNA normalization candidates for quantitative reverse-transcriptase polymerase chain reaction in real time in lesional and nonlesional psoriatic skin.

artículo científico publicado en 2013

MicroRNA-106b Regulates Expression of the Tumour Suppressors p21 and TXNIP and Promotes Tumour Cell Proliferation in Mycosis Fungoides

scientific article published on 18 June 2020

Mitogen- and stress-activated protein kinase 2 and cyclic AMP response element binding protein are activated in lesional psoriatic epidermis

artículo científico publicado en 2007

Non-random Plaque-site Recurrence of Psoriasis in Patients Treated with Dead Sea Climatotherapy

scientific article published on 01 September 2019

Pathway Analysis of Skin from Psoriasis Patients after Adalimumab Treatment Reveals New Early Events in the Anti-Inflammatory Mechanism of Anti-TNF-α

artículo científico publicado en 2016

Preferential inhibition of the mRNA expression of p38 mitogen-activated protein kinase regulated cytokines in psoriatic skin by anti-TNFα therapy.

artículo científico publicado en 2010

Pro-inflammatory cytokine release in keratinocytes is mediated through the MAPK signal-integrating kinases.

artículo científico publicado en 2007

Prognostic miRNA classifier in early-stage mycosis fungoides: development and validation in a Danish nationwide study

artículo científico publicado en 2017

Protein expression of TNF-alpha in psoriatic skin is regulated at a posttranscriptional level by MAPK-activated protein kinase 2.

artículo científico publicado en 2006

Protein phosphatase 2Cδ/Wip1 regulates phospho-p90RSK2 activity in lesional psoriatic skin.

artículo científico publicado en 2017

Reduced oxazolone-induced skin inflammation in MAPKAP kinase 2 knockout mice.

artículo científico publicado en 2008

Role of p38 mitogen-activated protein kinase isoforms in murine skin inflammation induced by 12-O-tetradecanoylphorbol 13-acetate.

artículo científico publicado en 2011

STAT1 expression and activation is increased in lesional psoriatic skin ⬇️

artículo científico publicado el 1 de febrero de 2013

STAT2 is involved in the pathogenesis of psoriasis by promoting CXCL11 and CCL5 production by keratinocytes

artículo científico publicado en 2017

Studies of Jak/STAT3 expression and signalling in psoriasis identifies STAT3-Ser727 phosphorylation as a modulator of transcriptional activity.

artículo científico publicado en 2013

TARC augments TNF-alpha-induced CTACK production in keratinocytes.

artículo científico publicado en 2004

TNFα- and IL-17A-mediated S100A8 expression is regulated by p38 MAPK.

artículo científico publicado en 2013

TRIM21 is important in the early phase of inflammation in the imiquimod-induced psoriasis-like skin inflammation mouse model.

artículo científico publicado en 2016

TSLP, IL-31, IL-33 and sST2 are new biomarkers in endophenotypic profiling of adult and childhood atopic dermatitis

artículo científico publicado en 2016

The "Alarmins" HMBG1 and IL-33 Downregulate Structural Skin Barrier Proteins and Impair Epidermal Growth.

artículo científico publicado en 2016

The MicroRNA Expression Profile Differs Between Erythrodermic Mycosis Fungoides and Sézary Syndrome

scientific article published on 01 November 2019

The activity of caspase-1 is increased in lesional psoriatic epidermis

scientific article published on 28 June 2007

The caspase-cleaved form of LYN mediates a psoriasis-like inflammatory syndrome in mice.

artículo científico publicado en 2009

The expression and phosphorylation of eukaryotic initiation factor 4E are increased in lesional psoriatic skin.

artículo científico publicado en 2009

The expression of dual-specificity phosphatase 1 mRNA is downregulated in lesional psoriatic skin.

artículo científico publicado en 2013

The human IL-17A/F heterodimer regulates psoriasis-associated genes through IκBζ

artículo científico publicado en 2018

The kinases MSK1 and MSK2 act as negative regulators of Toll-like receptor signaling

artículo científico publicado en 2008

The mitogen-activated protein kinases p38 and ERK1/2 are increased in lesional psoriatic skin

scientific article published on 01 January 2005

The p38 MAPK regulates IL-24 expression by stabilization of the 3' UTR of IL-24 mRNA.

artículo científico publicado en 2010

The role of leptin in psoriasis comprises a proinflammatory response by the dermal fibroblast

artículo científico publicado en 2015

The role of mitogen- and stress-activated protein kinase 1 and 2 in chronic skin inflammation in mice.

artículo científico publicado en 2010

Tumor necrosis factor α-mediated induction of interleukin 17C in human keratinocytes is controlled by nuclear factor κB.

artículo científico publicado en 2011

Tumor necrosis factor-alpha-induced CTACK/CCL27 (cutaneous T-cell-attracting chemokine) production in keratinocytes is controlled by nuclear factor kappaB.

artículo científico publicado en 2005

Tumour necrosis factor-α plays a significant role in the Aldara-induced skin inflammation in mice.

artículo científico publicado en 2015

Ustekinumab in the treatment of refractory chronic cutaneous lupus erythematosus: a case report

artículo científico publicado en 2013

Lista de obras de Claus Johansen

1alpha,25(OH)(2)D(3) regulates NF-kappaB DNA binding activity in cultured normal human keratinocytes through an increase in IkappaBalpha expression.

1alpha,25-dihydroxyvitamin D3 induced differentiation of cultured human keratinocytes is accompanied by a PKC-independent regulation of AP-1 DNA binding activity

1alpha,25-dihydroxyvitamin D3 stimulates activator protein 1 DNA-binding activity by a phosphatidylinositol 3-kinase/Ras/MEK/extracellular signal regulated kinase 1/2 and c-Jun N-terminal kinase 1-dependent increase in c-Fos, Fra1, and c-Jun express

A Characterization of the expression of 14-3-3 isoforms in psoriasis, basal cell carcinoma, atopic dermatitis and contact dermatitis

Activator protein 1 DNA binding activity is decreased in lesional psoriatic skin compared with nonlesional psoriatic skin.

Adalimumab therapy rapidly inhibits p38 mitogen-activated protein kinase activity in lesional psoriatic skin preceding clinical improvement.

Aldara®-induced skin inflammation: studies of patients with psoriasis.

Anti-inflammatory effect of a retrovirus-derived immunosuppressive peptide in mouse models

Antibiotics inhibit tumor and disease activity in cutaneous T-cell lymphoma

CCL27 expression is regulated by both p38 MAPK and IKKβ signalling pathways.

Caspase-5 expression is upregulated in lesional psoriatic skin

Changes in mRNA expression precede changes in microRNA expression in lesional psoriatic skin during treatment with adalimumab

Characterization of TNF-α- and IL-17A-Mediated Synergistic Induction of DEFB4 Gene Expression in Human Keratinocytes through IκBζ.

Characterization of the interleukin-17 isoforms and receptors in lesional psoriatic skin

Comment on 'Tumour necrosis factor-α plays a significant role in the Aldara-induced skin inflammation in mice': reply from authors.

Comparative Analysis of Two Gene-Targeting Approaches Challenges the Tumor-Suppressive Role of the Protein Kinase MK5/PRAK

Differential Effects of Digoxin on Imiquimod-Induced Psoriasis-Like Skin Inflammation on the Ear and Back

Dimethylfumarate inhibits MIF-induced proliferation of keratinocytes by inhibiting MSK1 and RSK1 activation and by inducing nuclear p-c-Jun (S63) and p-p53 (S15) expression.

Dimethylfumarate specifically inhibits the mitogen and stress-activated kinases 1 and 2 (MSK1/2): possible role for its anti-psoriatic effect.

Efficacy of ustekinumab in palmoplantar pustulosis and palmoplantar pustular psoriasis

Expression and Localization of Peroxisome Proliferator-Activated Receptors and Nuclear Factor κB in Normal and Lesional Psoriatic Skin

Generation and Culturing of Primary Human Keratinocytes from Adult Skin.

IL-17F regulates psoriasis-associated genes through IκBζ.

IL-20 gene expression is induced by IL-1beta through mitogen-activated protein kinase and NF-kappaB-dependent mechanisms

IL-20, IL-21 and p40: potential biomarkers of treatment response for ustekinumab.

IL-8 and p53 are inversely regulated through JNK, p38 and NF-kappaB p65 in HepG2 cells during an inflammatory response.

Inflammasomes and inflammatory caspases in skin inflammation

Inflammation-induced alterations in the skin barrier function: implications in atopic dermatitis.

Inflammatory cytokines break down intrinsic immunological tolerance of human primary keratinocytes to cytosolic DNA.

Interleukin 20 protein locates to distinct mononuclear cells in psoriatic skin

Interleukin 20 regulates dendritic cell migration and expression of co-stimulatory molecules.

Interleukin-23 in early disease development in rheumatoid arthritis.

Inverse regulation of the nuclear factor-kappaB binding to the p53 and interleukin-8 kappaB response elements in lesional psoriatic skin.

Investigating the Role of I Kappa B Kinase ε in the Pathogenesis of Psoriasis

IκBζ is a key driver in the development of psoriasis

IκBζ: A key protein in the pathogenesis of psoriasis

Kinetics and differential expression of the skin-related chemokines CCL27 and CCL17 in psoriasis, atopic dermatitis and allergic contact dermatitis

Langerhans cell markers CD1a and CD207 are the most rapidly responding genes in lesional psoriatic skin following adalimumab treatment.

Leptin deficiency in mice counteracts imiquimod (IMQ)-induced psoriasis-like skin inflammation while leptin stimulation induces inflammation in human keratinocytes.

Lysophosphatidylcholine induces keratinocyte differentiation and upregulation of AP-1- and NF-kappaB DNA-binding activity

MK2 regulates the early stages of skin tumor promotion.

Measuring serum concentrations of interleukin-33 in atopic dermatitis is associated with potential false positive results.

Mice lacking MSK1 and MSK2 show reduced skin tumor development in a two-stage chemical carcinogenesis model.

MicroRNA normalization candidates for quantitative reverse-transcriptase polymerase chain reaction in real time in lesional and nonlesional psoriatic skin.

MicroRNA-106b Regulates Expression of the Tumour Suppressors p21 and TXNIP and Promotes Tumour Cell Proliferation in Mycosis Fungoides

Mitogen- and stress-activated protein kinase 2 and cyclic AMP response element binding protein are activated in lesional psoriatic epidermis

Non-random Plaque-site Recurrence of Psoriasis in Patients Treated with Dead Sea Climatotherapy

Pathway Analysis of Skin from Psoriasis Patients after Adalimumab Treatment Reveals New Early Events in the Anti-Inflammatory Mechanism of Anti-TNF-α

Preferential inhibition of the mRNA expression of p38 mitogen-activated protein kinase regulated cytokines in psoriatic skin by anti-TNFα therapy.

Pro-inflammatory cytokine release in keratinocytes is mediated through the MAPK signal-integrating kinases.

Prognostic miRNA classifier in early-stage mycosis fungoides: development and validation in a Danish nationwide study

Protein expression of TNF-alpha in psoriatic skin is regulated at a posttranscriptional level by MAPK-activated protein kinase 2.

Protein phosphatase 2Cδ/Wip1 regulates phospho-p90RSK2 activity in lesional psoriatic skin.

Reduced oxazolone-induced skin inflammation in MAPKAP kinase 2 knockout mice.

Role of p38 mitogen-activated protein kinase isoforms in murine skin inflammation induced by 12-O-tetradecanoylphorbol 13-acetate.

STAT1 expression and activation is increased in lesional psoriatic skin ⬇️

STAT2 is involved in the pathogenesis of psoriasis by promoting CXCL11 and CCL5 production by keratinocytes

Studies of Jak/STAT3 expression and signalling in psoriasis identifies STAT3-Ser727 phosphorylation as a modulator of transcriptional activity.

TARC augments TNF-alpha-induced CTACK production in keratinocytes.

TNFα- and IL-17A-mediated S100A8 expression is regulated by p38 MAPK.

TRIM21 is important in the early phase of inflammation in the imiquimod-induced psoriasis-like skin inflammation mouse model.

TSLP, IL-31, IL-33 and sST2 are new biomarkers in endophenotypic profiling of adult and childhood atopic dermatitis

The "Alarmins" HMBG1 and IL-33 Downregulate Structural Skin Barrier Proteins and Impair Epidermal Growth.

The MicroRNA Expression Profile Differs Between Erythrodermic Mycosis Fungoides and Sézary Syndrome

The activity of caspase-1 is increased in lesional psoriatic epidermis

The caspase-cleaved form of LYN mediates a psoriasis-like inflammatory syndrome in mice.

The expression and phosphorylation of eukaryotic initiation factor 4E are increased in lesional psoriatic skin.

The expression of dual-specificity phosphatase 1 mRNA is downregulated in lesional psoriatic skin.

The human IL-17A/F heterodimer regulates psoriasis-associated genes through IκBζ

The kinases MSK1 and MSK2 act as negative regulators of Toll-like receptor signaling

The mitogen-activated protein kinases p38 and ERK1/2 are increased in lesional psoriatic skin

The p38 MAPK regulates IL-24 expression by stabilization of the 3' UTR of IL-24 mRNA.

The role of leptin in psoriasis comprises a proinflammatory response by the dermal fibroblast

The role of mitogen- and stress-activated protein kinase 1 and 2 in chronic skin inflammation in mice.

Tumor necrosis factor α-mediated induction of interleukin 17C in human keratinocytes is controlled by nuclear factor κB.

Tumor necrosis factor-alpha-induced CTACK/CCL27 (cutaneous T-cell-attracting chemokine) production in keratinocytes is controlled by nuclear factor kappaB.

Tumour necrosis factor-α plays a significant role in the Aldara-induced skin inflammation in mice.

Ustekinumab in the treatment of refractory chronic cutaneous lupus erythematosus: a case report